NL
DE
Less damage to organs and a greater chance of survival after having a heart attack. That's what Radboudumc spin-off CardiacBooster is aiming to accomplish.
Related news items
Meet Healthy Ideas, Healthy Returns
2 June 2023Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.
read more
Kick-off collaboration on 3D printed orthoses with Spentys and atum3D
7 February 2023atum3D and Spentys hosted a workshop on 3D printed orthoses, a break-through development made possible through collaboration with the Department of Surgery - Trauma Unit and the 3D lab of Radboudumc.
read more
Job opportunity: Program Manager Health Incubator at SMB
17 January 2023Science Meets Business (SMB) is looking for a community builder to manage and expand the incubator and maintain relationships with the stakeholders.
read more
Help Cell4Pharma to reduce animal testing in drug development
21 December 2022More than 50 million animals are used for medical experiments each year in the United States alone. But we have an alternative!
read moreAftermovie Investment Day 2022 and a new date for 2023!
13 December 2022Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.
read moreJoining forces increases innovation Janssen and Radboud
1 December 2022Dr. Eng Kinga MatuĊa (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.
read more